Literature DB >> 9813008

Enhancement of human protein C function by site-directed mutagenesis of the gamma-carboxyglutamic acid domain.

L Shen1, A M Shah, B Dahlbäck, G L Nelsestuen.   

Abstract

This study reports properties of site-directed mutants of human protein C that display enhanced calcium and/or membrane binding properties. Mutants containing the S11G modification all showed increased affinity for membranes at saturating calcium concentration. Ser-11 is unique to human protein C, whereas all other vitamin K-dependent proteins contain glycine. This site is located in a compact region of the protein, close to a suggested membrane contact site. Additional changes of H10Q or S12N resulted in proteins with lower calcium requirement for membrane contact but without further increase in membrane affinity at saturating calcium. Mutations Q32E and N33D did not, by themselves, alter membrane affinity to a significant degree. These mutations were included in other mutant proteins and may contribute somewhat to higher function in these mutants. This family of mutants helped discriminate events that are necessary for protein-membrane binding. These include calcium binding to the free protein and subsequent protein-membrane contact. Depending on conditions of the assay used, the mutants displayed increased activity of the corresponding activated protein C (APC) derivatives. The degree of enhanced activity (up to 10-fold) was dependent on the concentration of phospholipid and quality of phospholipid (+/- phosphatidylethanolamine) used in the assay. This was expected, because APC is active in its membrane-associated form, which can be regulated by changes in either the protein or phospholipid. As expected, the largest impact of the mutants occurred at low phospholipid concentration and in the absence of phosphatidylethanolamine. The anticoagulant activity of all proteins was stimulated by protein S, with the greatest impact on the enhanced mutants. Whereas plasma containing Factor V:R506Q was partially resistant to all forms of APC, the enhanced variants were more active than normal APC. Protein C variants with enhanced function present new reagents for study of coagulation and may offer improved materials for biomedical applications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813008     DOI: 10.1074/jbc.273.47.31086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Inhibition of thrombin formation by active site mutated (S360A) activated protein C.

Authors:  Gerry A F Nicolaes; Paul E Bock; Kenneth Segers; Karin C A A Wildhagen; Björn Dahlbäck; Jan Rosing
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

2.  Modeling zymogen protein C.

Authors:  L Perera; C Foley; T A Darden; D Stafford; T Mather; C T Esmon; L G Pedersen
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

3.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

4.  Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S.

Authors:  José A Fernández; Xiao Xu; Ranjeet K Sinha; Laurent O Mosnier; Michel F Sanner; John H Griffin
Journal:  Blood Adv       Date:  2017-08-07

5.  Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium.

Authors:  Kanagasabai Vadivel; Sayeh Agah; Amanda S Messer; Duilio Cascio; Madhu S Bajaj; Sriram Krishnaswamy; Charles T Esmon; Kaillathe Padmanabhan; S Paul Bajaj
Journal:  J Mol Biol       Date:  2013-02-20       Impact factor: 5.469

6.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013

7.  Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C.

Authors:  Shabir H Qureshi; Likui Yang; Chandrashekhara Manithody; Jong-Sup Bae; Alireza R Rezaie
Journal:  Biochim Biophys Acta       Date:  2008-05-19

8.  Computational study of coagulation factor VIIa's affinity for phospholipid membranes.

Authors:  Olivier Taboureau; Ole Hvilsted Olsen
Journal:  Eur Biophys J       Date:  2006-11-28       Impact factor: 2.095

9.  The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

Authors:  Magdalena Gierula; Isabelle I Salles-Crawley; Salvatore Santamaria; Adrienn Teraz-Orosz; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  J Thromb Haemost       Date:  2019-08-09       Impact factor: 5.824

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.